Filing Flows › Ingevity (NGVT) › Q3 2026
Ingevity (NGVT) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Ingevity (NGVT) reported revenue of $305M for the third quarter 2026 (Q3 2026), -8% from a year earlier and -3% from the quarter before. Operating margin was 22.0%, net earnings $49.3M (16.2% of revenue).
Ingevity, Q3 2026: revenue $305M (-8% year over year), operating margin 22.0%, net earnings $49.3M, operating cash flow $99.2M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $305M | -3% | -8% |
| Gross profit | $133M | -4% | -0.8% |
| Operating profit | $67.1M | +45% | +3% |
| Net earnings | $49.3M | +40% | +13% |
| Operating cash flow | $99.2M | — | -24% |
| Free cash flow | $85.5M | — | -27% |
What changed
Revenue was $305.1M in Q3 2026, down 8% year over year and down 3% from the previous quarter. Performance Materials was the largest line at 51% of revenue. Pavement Technologies Segment lost $33.9M year over year (down 24%), 121% of the total change.
Gross margin was 43.5%, up 3.3 points from Q3 2025. Operating profit was $67.1M, a 22.0% margin (up 2.5 points year over year). Operating expenses fell 5% while revenue fell 8%. The fastest-growing cost line was Research & development (+19%). Net earnings were $49.3M, up 13% year over year. The effective tax rate was 26.5%.
Operating cash flow was $99.2M (down 24% year over year), 201% of net earnings. Non-cash charges added back $20.9M of depreciation and amortization and $4.0M of share-based compensation. Working capital and other items added $25.0M. After capital expenditures ($13.7M), free cash flow as the company reports it was $85.5M.
Questions
What was Ingevity's revenue in the third quarter 2026?
Ingevity (NGVT) reported revenue of $305M for the third quarter 2026 (Q3 2026), -8% from a year earlier and -3% from the quarter before.
Was Ingevity profitable in the third quarter 2026?
Operating profit was $67.1M (22.0% of revenue) and net earnings $49.3M.
Source: Ingevity 10-Q on SEC EDGAR.